Hyloris Announces FDA Acceptance of New Drug Application for Maxigesic® IV in Post ...

: Written by: Drug News Feed; Category: Drug News; Published: 01 November 2021; Hits: 660

Maxigesic® IV has the potential to combat the opioid crisis in the U.S.. Liège, Belgium – 1 November 2021 – Hyloris Pharmaceuticals SA (Euronext ...

Read more https://www.google.com/url?rct=j&sa=t&url=https://www.streetinsider.com/Globe%2BNewswire/Hyloris%2BAnnounces%2BFDA%2BAcceptance%2Bof%2BNew%2BDrug%2BApplication%2Bfor%2BMaxigesic%25C2%25AE%2BIV%2Bin%2BPost-Operative%2BPain/19133376.html&ct=ga&cd=CAIyHGUxNmUxOWQ1ZmFmZjE2ZDU6Y29tOmVuOlVTOlI&usg=AFQjCNGZSAcQGXeACEUpxZahqJ_xdceYOA